About the Event

The Hunter Medical Research Institute and the Mark Hughes Foundation are proud to welcome international brain cancer expert Dr Susan Chang and Research Fellow Dr Mike Fay to talk on their current research at the Brain Cancer Public Seminar, October 13, 2018.

Hear from two world leading researchers, Dr Mike Fay and Dr Susan Chang, who will be happy to answer your questions about current and future brain cancer treatments. At this seminar you will not only hear about the exciting research being undertaken in the Hunter, but be given a firsthand account of research and treatments from across the globe.

To register your attendance, visit https://hmri.org.au/events/brain-cancer-public-seminar

dr mike fay 220Dr Mike Fay is a nationally renowned radiation oncologist who was the inaugural recipient of the HMRI Mid-Career research Fellowship in Brain Cancer supported by the Mark Hughes Foundation. Mike’s research focusses on specially targeted therapies based on targeted diagnostic tests.

susan chang 220Dr Susan Chang is the Director of the UCSF Division of Neuro-Oncology and is an internationally recognized leader in the field of neurological malignancies. Her research expertise is in clinical trial design and the development of novel therapies and imaging biomarkers for brain tumors. Dr. Chang is the principal investigator and co-investigator on more than 20 active clinical trials that evaluate the wide spectrum of therapeutic interventions, spanning chemotherapy, targeted agents, immunotherapy, and convection-enhanced delivery of novel agents. Dr. Chang also has a strong interest in quality-of-life issues faced by patients with brain tumors and their families.